Dec 13, 2024

Modular Content Revolution: Pharma's Answer to Personalization at Scale

Modular Content Revolution: Pharma's Answer to Personalization at Scale

Here’s a challenge that keeps pharmaceutical marketers up at night: how do you deliver personalized content to thousands of healthcare professionals across multiple specialties, channels, and regions—while maintaining perfect compliance? The traditional answer has been “you can’t.” But innovative companies like UCB are proving that wrong with modular content.

UCB’s approach is revolutionary not because they invented modular content, but because they’ve scaled it across their entire pharmaceutical operation. Jennifer T, Head of Omnichannel at UCB, explains their reality: “Currently, the current state is developers are hands-on, keyboard coding HTML for every single banner, every single email, think about how inefficient that is.”

The modular content revolution isn’t just about efficiency—it’s about creating personalized experiences at scale that respect both HCP needs and regulatory requirements.

The Traditional Content Problem in Pharma

Before we dive into the solution, understand the magnitude of the challenge:

Traditional Pharma Content Creation:

  • Manual Process: Each piece of content created from scratch
  • Channel Silos: Different content for email, web, social, sales reps
  • Regional Variations: 50+ countries need localized versions
  • Compliance Bottlenecks: Every version requires MLR review
  • Inconsistent Messaging: No guarantee of brand consistency

The Result: Content teams taking weeks to create campaigns that may be outdated before they launch.

1. What Is Modular Content in Pharma?

Modular content breaks information into approved, reusable components that can be dynamically assembled based on audience, channel, and context.

The Building Blocks:

Modular Content Components:

📋 Header Modules (approved headlines, CTAs)

📊 Clinical Data Blocks (study results, statistics)

⚠️ Safety Information (side effects, warnings)

🎨 Visual Elements (images, infographics, videos)

📜 Regulatory Statements (indications, contraindications)

📞 Contact Information (rep details, medical information)

📄 Footer Elements (legal disclaimers, privacy policies)

The Magic: Each component is MLR-approved once, then reused thousands of times in different combinations.

2. The UCB Implementation: From Chaos to Control

UCB’s journey provides the blueprint for pharmaceutical companies at any scale.

Phase 1: Component Creation UCB started by breaking down their existing content into reusable modules:

  • Analyzed 1,000+ pieces of content to identify common elements
  • Created 200+ approved components covering all clinical areas
  • Established business rules for which components can combine
  • Built compliance guardrails to prevent prohibited combinations

Phase 2: Technology Enablement UCB leverages existing tools rather than building custom solutions:

  • Salesforce Marketing Cloud for content assembly
  • AI Algorithms for personalization decisions
  • Automated MLR Integration for compliance checks
  • Dynamic Content Delivery across all channels

Jennifer’s Insight: “We have content that can ride along together. There are all sorts of business rules for what can live together, what must always live together and what absolutely cannot go together from a compliance standpoint.”

3. The Assembly Line: Creating Personalized Content Automatically

Here’s how modular content creates personalized experiences at scale:

Step 1: Audience Understanding

  • Specialty Identification: Cardiologist vs. neurologist vs. primary care
  • Channel Preferences: Email vs. WhatsApp vs. HCP portal
  • Engagement History: Previous content interactions and responses
  • Clinical Context: Geographic practice patterns, patient demographics

Step 2: Dynamic Assembly Based on the audience profile, the system selects appropriate components:

  • Cardiologist + Email: Clinical study data + cardiology-specific safety info + CME invitation
  • Primary Care + WhatsApp: Quick reference guide + patient resources + rep contact
  • Hospital Pharmacist + Portal: Formulary information + dosing guidelines + ordering details

Step 3: Compliance Validation Every assembled piece goes through automated compliance checks:

  • Business Rules Validation: Ensures only approved combinations
  • Regulatory Requirements: Country-specific statements and warnings
  • MLR Integration: Automatic flagging of new combinations for review

4. The Personalization Engine: Smart Content Selection

UCB uses AI to make intelligent content decisions, going beyond simple if-then rules.

Real Example: An oncologist who previously engaged with immunotherapy content receives:

  • Header: Recent advancement in immunotherapy
  • Clinical Data: Specific response rates for their cancer type
  • Visual: Mechanism of action infographic
  • Safety: Profiled side effects for their patient population
  • CTA: Personalized invitation to upcoming webinar

The Intelligence: The system learns that this oncologist prefers visual explanations and responds to data about patient outcomes specific to their practice.

5. The Efficiency Revolution: From Weeks to Minutes

The impact on content creation speed is transformative:

Before Modular Content:

  • Campaign development: 4-6 weeks
  • Localization: 2-3 weeks per country
  • Compliance review: 1-2 weeks per version
  • Total time: 8-11 weeks per campaign

After Modular Content:

  • Campaign development: 2-3 days (component assembly)
  • Localization: Automated for approved components
  • Compliance review: Pre-approved components only
  • Total time: 3-5 days per campaign

The ROI: 90% reduction in content creation time with 10x improvement in personalization capabilities.

Building Your Modular Content System: 6-Month Roadmap

You don’t need UCB’s resources to start. Here’s how to implement modular content progressively:

Month 1-2: Foundation

  • Content Audit: Analyze your top 50 most-used content pieces
  • Component Identification: Find repeated elements across content
  • Business Rules Definition: Document which elements can combine
  • MLR Alignment: Get compliance team buy-in early

Month 3-4: Technology Setup

  • Choose Platform: Start with existing marketing automation tools
  • Component Library: Build first 50 approved components
  • Testing Framework: Create validation rules and processes
  • Team Training: Teach content teams modular thinking

Month 5-6: Launch and Optimize

  • Pilot Program: Launch with one therapeutic area
  • Performance Tracking: Measure engagement and efficiency gains
  • Iterate: Refine components based on performance
  • Scale: Plan expansion to other areas

The Compliance Advantage

Modular content doesn’t just improve efficiency—it enhances compliance:

Prevention Benefits:

  • Single Source of Truth: Each component approved once, used everywhere
  • Automated Validation: System prevents prohibited combinations
  • Version Control: Clear tracking of component changes and approvals
  • Audit Trail: Complete visibility into content assembly

Response Benefits:

  • Rapid Updates: Change one component, update thousands of pieces
  • Crisis Management: Quickly remove or replace problematic content
  • Regulatory Changes: Update compliance statements across all channels
  • Safety Communications: Instantly add new safety information everywhere

Measuring Modular Content Success

Track metrics that demonstrate both efficiency and effectiveness:

Efficiency Metrics:

  • Content Creation Speed: Time from brief to deployment
  • Reuse Rate: Percentage of content using existing components
  • Localization Speed: Time to adapt for new markets
  • Compliance Cycle Time: MLR review duration

Effectiveness Metrics:

  • Personalization Score: Degree of content customization
  • Engagement Rates: Opens, clicks, time spent with content
  • Response Quality: HCP-initiated follow-up conversations
  • Business Impact: Formulary access, prescribing patterns (where measurable)

Common Implementation Challenges

Challenge 1: Component Overload Solution: Start small with 20-30 most-used components. Expand based on usage data.

Challenge 2: Business Rule Complexity Solution: Begin with simple combination rules. Add complexity gradually with clear documentation.

Challenge 3: Creative Resistance Solution: Show teams how modular content frees them for strategy rather than repetitive tasks.

Challenge 4: Technology Integration Solution: Use existing marketing automation tools before building custom solutions.

The Future of Pharma Content

The modular content revolution is just beginning. As AI becomes more sophisticated, we’ll see:

  • Predictive Assembly: AI anticipates content needs before requests
  • Dynamic Optimization: Real-time content adjustment based on engagement
  • Hyper-Personalization: Individual-level content customization
  • Voice Integration: Content assembly for voice assistants and smart speakers

UCB is already moving in this direction. As Jennifer notes, “The intention is that within our data warehouse, over the next few years, we will internalize that sort of as a CDP.”

The Strategic Imperative

The pharmaceutical companies that master modular content will have significant competitive advantages:

  • Speed to Market: Launch campaigns in days, not months
  • Personalization at Scale: Treat every HCP as an individual
  • Global Consistency: Maintain brand voice across all markets
  • Compliance Confidence: Reduce regulatory risk through automation

The question isn’t whether your pharmaceutical company will adopt modular content—it’s whether you’ll lead the revolution or be forced to follow those who do.


Pharma Strategy Series:

About Caramel

Caramel helps pharmaceutical companies implement modular content strategies that deliver personalized experiences at scale. Learn how our AI-powered platform can transform your content creation process while maintaining perfect compliance.

Related Blogs

See All Blog
Caramel vs Mailmodo: When AMP Emails Are Not Enough for a Real B2C CRM Caramel vs Mailmodo: When AMP Emails Are Not Enough for a Real B2C CRM

Caramel vs Mailmodo: When AMP Emails Are Not Enough for a Real B2C CRM

Mailmodo earned a real place in the email marketing market by doing one thing well: making emails interactive. Forms, polls, quizzes, calend

26 May, 2026
Personalisation at Scale: How AI Delivers 1-to-1 Marketing Without 1-to-1 Human Effort Personalisation at Scale: How AI Delivers 1-to-1 Marketing Without 1-to-1 Human Effort

Personalisation at Scale: How AI Delivers 1-to-1 Marketing Without 1-to-1 Human Effort

Personalisation is the word the marketing industry has used for fifteen years to describe everything from inserting a first name into an ema

12 May, 2026
Compliance by Design: KYC, AML and Cross-Border Rules Handled by Your AI Agent Compliance by Design: KYC, AML and Cross-Border Rules Handled by Your AI Agent

Compliance by Design: KYC, AML and Cross-Border Rules Handled by Your AI Agent

International buyers generate compliance obligations that domestic buyers do not. This is not a regulatory inconvenience — it is a structura

10 May, 2026
Take Back Control

Stop Paying Commissions. Start Building Relationships.

Join forward-thinking businesses reclaiming their customer data from third-party platforms. Build direct connections, increase loyalty, and keep 100% of your revenue.

Book Demo
CTA
CTA
CTA